PD-002A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. (20th June 2018) - Chajon, E; Pracht, M; De Baere, T; Nguyen, F; Bronowicki, J; Vendrely, V; Baumann, A; Croisé-Laurent, V; Rio, E; Rolland, Y; Le Sourd, S; Gustin, P; et al.